Overview
Abridge is a U.S. provider of AI services for medical conversations.
Funding
Amounts as reported; USD estimates shown only when they matchListed 5 funding records. Latest funding: $300M (Series E), Jun 25, 2025.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 25, 2025 | $300M · Series E | Andreessen Horowitz, Khosla Ventures | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Feb 17, 2025 | $250M · Series D | Bessemer Venture Partners, CapitalG, CHCF, Circle K Ventures, CVS Health Ventures, Elad Gil, IVP, Lightspeed Venture Partners, NVIDIA, Redpoint Ventures, Spark Capital, SVA | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, CapitalG, CHCF, Circle K Ventures, CVS Health Ventures, Elad Gil, IVP, Lightspeed Venture Partners, NVIDIA, Redpoint Ventures, Spark Capital, SVA | |||
| Oct 10, 2024 | $250M | Bessemer Venture Partners, California Health Care Foundation, CapitalG, Elad Gil, IVP, NVIDIA | 1 source Source ↗ |
Evidence Elad Gil's latest AI bet is in healthcare; Abridge seeks USD 250 million at a USD 1 billion valuationOn 2024/10/10, The Information reported that Abridge, a US healthcare AI company, was raising USD 250 million at a USD 1 billion valuation, with approximately USD 50 million in annual revenue. It uses AI to transcribe doctor-patient conversations and automatically generate medical records, representing Elad Gil's latest investment in healthcare AI. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Bessemer Venture Partners, California Health Care Foundation, CapitalG, Elad Gil, IVP, NVIDIA | |||
| Feb 23, 2024 | $150M · Series C | Bessemer Venture Partners, CVS Health Ventures, IVP, KaiserPemmanente Ventures, Lightspeed Venture Partners, Spark Capital, Union Square Ventures, WittinatonVentures.AlDlF, 红点海外 | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, CVS Health Ventures, IVP, KaiserPemmanente Ventures, Lightspeed Venture Partners, Spark Capital, Union Square Ventures, WittinatonVentures.AlDlF, 红点海外 | |||
| Aug 12, 2022 | $12.5M · Series A | Bessemer Venture Partners, Pillar, Union Square Ventures, UPMC, Whistler Capital, Wittington Ventures, Yoshua Bengio | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, Pillar, Union Square Ventures, UPMC, Whistler Capital, Wittington Ventures, Yoshua Bengio | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 5 valuation records. Latest valuation: $1B, Oct 10, 2024.
4 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 25, 2025 | — · Series E | Andreessen Horowitz, Khosla Ventures | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Feb 17, 2025 | — · Series D | Bessemer Venture Partners, CapitalG, CHCF, Circle K Ventures, CVS Health Ventures, Elad Gil, IVP, Lightspeed Venture Partners, NVIDIA, Redpoint Ventures, Spark Capital, SVA | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, CapitalG, CHCF, Circle K Ventures, CVS Health Ventures, Elad Gil, IVP, Lightspeed Venture Partners, NVIDIA, Redpoint Ventures, Spark Capital, SVA | |||
| Oct 10, 2024 | $1B | Bessemer Venture Partners, California Health Care Foundation, CapitalG, Elad Gil, IVP, NVIDIA | 1 source Source ↗ |
Evidence Elad Gil's latest AI bet is in healthcare; Abridge seeks USD 250 million at a USD 1 billion valuationOn 2024/10/10, The Information reported that Abridge, a US healthcare AI company, was raising USD 250 million at a USD 1 billion valuation, with approximately USD 50 million in annual revenue. It uses AI to transcribe doctor-patient conversations and automatically generate medical records, representing Elad Gil's latest investment in healthcare AI. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Bessemer Venture Partners, California Health Care Foundation, CapitalG, Elad Gil, IVP, NVIDIA | |||
| Feb 23, 2024 | — · Series C | Bessemer Venture Partners, CVS Health Ventures, IVP, KaiserPemmanente Ventures, Lightspeed Venture Partners, Spark Capital, Union Square Ventures, WittinatonVentures.AlDlF, 红点海外 | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, CVS Health Ventures, IVP, KaiserPemmanente Ventures, Lightspeed Venture Partners, Spark Capital, Union Square Ventures, WittinatonVentures.AlDlF, 红点海外 | |||
| Aug 12, 2022 | — · Series A | Bessemer Venture Partners, Pillar, Union Square Ventures, UPMC, Whistler Capital, Wittington Ventures, Yoshua Bengio | No source link |
Evidence No source brief is attached to this record. Sources · 0
Bessemer Venture Partners, Pillar, Union Square Ventures, UPMC, Whistler Capital, Wittington Ventures, Yoshua Bengio | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchListed 5 revenue records. Latest revenue: $117M (ARR), May 20, 2025.
| Revenue date | Amount | Sources |
|---|---|---|
| May 20, 2025 | $117M (ARR) | 1 source Source ↗ |
Evidence Abridge reaches USD 117 million in contracted ARR; actual ARR may be near USD 100 millionOn 2025/5/20, The Information reported, citing people familiar with the matter, that Abridge reached USD 117 million in contracted annual recurring revenue in the first quarter of 2025. The contracted amount included contracts that had not yet begun billing; actual ARR was reportedly potentially near USD 100 million. Funding and an approximately USD 5 billion valuation remained under discussion, rather than a completed transaction. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Mar 14, 2025 | $117M (ARR) | 1 source Source ↗ |
Evidence Abridge reaches USD 117 million in ARROn 2025/3/14, ARR Club reported that Abridge disclosed annual recurring revenue (ARR) of USD 117 million in the AI Healthcare sector. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Dec 26, 2024 | $60M (ARR) | 1 source Source ↗ |
Evidence Abridge reaches USD 60 million ARROn 2024/12/26, ARR Club reported that US medical AI company Abridge had disclosed USD 60 million in annual recurring revenue. It automatically transcribes doctor-patient conversations and generates clinical notes, with ARR continuing to grow from USD 50 million in month 10. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Oct 17, 2024 | $50M (ARR) | 1 source Source ↗ |
Evidence Abridge reaches USD 50 million in ARROn 2024/10/17, ARR Club reported that Abridge disclosed annual recurring revenue (ARR) of USD 50 million in the AI Healthcare sector. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Oct 10, 2024 | $50M | 1 source Source ↗ |
Evidence Elad Gil's latest AI bet is in healthcare; Abridge seeks USD 250 million at a USD 1 billion valuationOn 2024/10/10, The Information reported that Abridge, a US healthcare AI company, was raising USD 250 million at a USD 1 billion valuation, with approximately USD 50 million in annual revenue. It uses AI to transcribe doctor-patient conversations and automatically generate medical records, representing Elad Gil's latest investment in healthcare AI. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
Select ▸ on a row to see its source brief and links.
Team, products & investors
Products
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
美国医疗对话AI服务商 Abridge是一家美国医疗对话AI服务商